Clinical Trial Update: Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mapatumumab with cisplatin and radiotherapy in advanced cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Mapatumumab (mapatumumab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Advanced Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED